Brennan Kevin M. 4
4 · Xilio Therapeutics, Inc. · Filed Apr 3, 2023
Insider Transaction Report
Form 4
Brennan Kevin M.
SVP, FINANCE AND ACCOUNTING
Transactions
- Award
Stock Option (right to buy)
2023-04-01+55,000→ 55,000 totalExercise: $3.17Exp: 2033-03-31→ Common Stock (55,000 underlying)
Footnotes (1)
- [F1]The option was granted on April 1, 2023 and shall vest on March 30, 2024 with respect to 25% of the shares of common stock underlying the stock option, and the remaining 75% of the shares of common stock underlying the stock option shall continue to vest in 36 equal monthly installments thereafter until March 30, 2027.